ETFs & Funds
) prescription food for Alzheimer's trial completes in March. Data will be presented mid-April. Bounced off 1.05!
Add a reply...
Latest StockTalks »
people get SYN breaking news and analysis by email alert.
Get email alerts on SYN »
Synthetic Biologics, Inc.
Get latest price
From other sites
The Zacks Analyst Blog Highlights: Corcept Therapeutics, Epizyme, Geron and Synthetic Biologics
at Zacks.com (Mar 29, 2016)
Synthetic Biologics Tanks on Unfavorable Trimesta Data
at Zacks.com (Feb 3, 2016)
Synthetic Biologics (SYN) Rises: Stock Adds 11% in Session
at Zacks.com (Nov 24, 2015)
Synthetic Biologics (SYN) in Focus: Stock Rises 14.6% - Tale of the Tape
at Zacks.com (Jul 15, 2015)
Synthetic Biologics Reports First Patient Dosed in Phase 1b Clinical Trial of SYN-004 for the Prevention of C. Difficile Infection
at Benzinga.com (Dec 30, 2014)